These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6240764

  • 1. Effect of ipratropium bromide on nasal mucociliary transport.
    Ohi M, Sakakura Y, Murai S, Miyoshi Y.
    Rhinology; 1984 Dec; 22(4):241-6. PubMed ID: 6240764
    [Abstract] [Full Text] [Related]

  • 2. Effect of ipratropium bromide on airway mucociliary function.
    Wanner A.
    Am J Med; 1986 Nov 14; 81(5A):23-7. PubMed ID: 2947458
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Modification in some nasal function parameters after metacholine stimulation and pretreatment with ipratropium bromide].
    Zanoletti E, De Paoli F, Regazzi Bonora M, Castenuovo P, Mevio E, Mira E.
    Acta Otorhinolaryngol Ital; 1999 Jun 14; 19(3):150-4. PubMed ID: 10546372
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mucociliary transport in the human nose. Effect of topical glucocorticoid treatment.
    Holmberg K, Pipkorn U.
    Rhinology; 1985 Sep 14; 23(3):181-5. PubMed ID: 4059802
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide.
    Laurikainen E, Koulu M, Kaila T, Scheinin M, Isalo E.
    Rhinology; 1988 Jun 14; 26(2):133-8. PubMed ID: 2972054
    [Abstract] [Full Text] [Related]

  • 8. The effect of ipratropium bromide (Atrovent) on the air conditioning capacity of the nose.
    Kumlien J, Drettner B.
    Clin Otolaryngol Allied Sci; 1985 Jun 14; 10(3):165-8. PubMed ID: 3161669
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of the nasal cilia. Preliminary study in healthy subjects.
    Nuutinen J.
    Rhinology; 1985 Mar 14; 23(1):3-10. PubMed ID: 4001757
    [Abstract] [Full Text] [Related]

  • 11. Dose effects of inhaled ipratropium bromide on the impedance of the respiratory system in normal subjects.
    Wesseling GJ, Vonk JM, Greve LH, Wouters EF.
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan 14; 28(1):33-8. PubMed ID: 2137435
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of 0.2 mg ipratropium bromide on mucociliary clearance in patients with chronic bronchitis.
    Matthys H, Hundenborn J, Daikeler G, Köhler D.
    Respiration; 1985 Jan 14; 48(4):329-39. PubMed ID: 2934779
    [Abstract] [Full Text] [Related]

  • 14. Effect of surface-active substance on nasal mucociliary clearance time: a comparison of saccharin clearance time before and after the use of surface-active substance.
    Outzen KE, Svane-Knudsen V.
    Rhinology; 1993 Dec 14; 31(4):155-7. PubMed ID: 8140381
    [Abstract] [Full Text] [Related]

  • 15. Influence of degradable starch microspheres on the human nasal mucosa.
    Holmberg K, Björk E, Bake B, Edman P.
    Rhinology; 1994 Jun 14; 32(2):74-7. PubMed ID: 7939145
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intranasal ipratropium in the treatment of vasomotor rhinitis.
    Jokinen K, Sipilä P.
    Rhinology; 1983 Dec 14; 21(4):341-5. PubMed ID: 6229864
    [Abstract] [Full Text] [Related]

  • 19. Vasomotor rhinitis and the systemic absorption of ipratropium bromide.
    Kaila T, Suonpää J, Grénman R, Iisalo E.
    Rhinology; 1990 Jun 14; 28(2):83-9. PubMed ID: 2143593
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.